ArticleFrontiers in pediatrics2025
Comparative evaluation of machine learning models for enhancing diagnostic accuracy of otitis media with effusion in children with adenoid hypertrophy.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Otitis media with effusion (OME) affects a significant proportion of children with adenoid hypertrophy (AH) and can lead to developmental sequelae when chronic. Current non-invasive screening modalities rely predominantly on acoustic immittance measurements, which demonstrate variable diagnostic performance. Given the urgent need for improved diagnostic methods and extensive characterization of risk factors for OME in AH children, developing diagnostic models represents an efficient strategy to enhance clinical identification accuracy in practice. Objective: This study aims to develop and validate an optimal machine learning (ML)-based prediction model for OME in AH children by comparing multiple algorithmic approaches, integrating clinical indicators with acoustic measurements into a widely applicable diagnostic tool. Methods: A retrospective analysis was conducted on 847 pediatric patients with AH. Five ML algorithms were developed to identify OME using demographic, clinical, laboratory, and acoustic immittance parameters. The dataset underwent 7:3 stratified partitioning for training and testing cohorts. Within the training cohort, models were initially optimized through randomized grid search with 5-fold cross-validation, followed by comprehensive training with optimized parameters. Model performance was evaluated in the testing cohort using discrimination, calibration, clinical utility metrics, and confusion matrix-derived statistics. The optimal ML model was subsequently analyzed through SHapley Additive exPlanations (SHAP) methodology for interpretability, with sequential ablation testing performed to identify critical predictive variables. Results: Among 847 children with AH, 262 (30.9%) were diagnosed with OME. The Random Forest (RF) model demonstrated superior performance with the highest discrimination (area under the receiver operating characteristic curve = 0.919), balanced calibration (Brier score = 0.102), and optimal clinical utility across decision thresholds of 0.4-0.6. Confusion matrix analysis further confirmed RF as the optimal model, achieving 0.875 accuracy and robust inter-rater agreement (Cohen's kappa coefficient = 0.696) in the testing cohort. SHAP analysis identified the adenoid-to-nasopharyngeal ratio as the predominant diagnostic indicator, followed by tympanometric type and history of recurrent respiratory infections. Conclusion: An RF-based diagnostic model effectively identifies OME in AH children by integrating anatomical, functional, and inflammatory parameters, providing a clinically applicable tool for enhanced diagnostic accuracy and evidence-based management decisions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.